Hillel Galitzer Net Worth

Hillel Galitzer biography

Dr. Hillel Galitzer M.D. serves as Chief Operating Officer of the Company. Dr. Galitzer has served as our Chief Operating Officer since February 2014, and prior to that served as our Director of Scientific Development from July 2012. Dr. Galitzer has more than ten years of experience in medical research and molecular biology. Between August 2010 and February 2014, Dr. Galitzer was an analyst and the chief operating officer for Hadasit Bio Holdings Ltd., a publicly traded company on the Tel Aviv Stock Exchange (TASE: HDST) and OTC markets. He has more than 10 years of experience in medical research and molecular biology. He is the co-founder and former chief operating officer of Optivasive Inc. He has written numerous publications in peer-reviewed journals and has lectured and presented in international conferences and universities. Dr. Galitzer received his Ph.D. from the Hebrew University Medical School in Jerusalem, where he was mentored by two world renowned researchers in the areas of parathyroid hormone and calcium regulation, his M.B.A. from Bar Ilan University in Israel and his B.Med.Sc. from the Hebrew University Medical School in Jerusalem.

What is the salary of Hillel Galitzer?

As the Chief Operating Officer of Entera Bio Ltd, the total compensation of Hillel Galitzer at Entera Bio Ltd is $367,393. There are 5 executives at Entera Bio Ltd getting paid more, with Phillip Schwartz having the highest compensation of $722,014.

How old is Hillel Galitzer?

Hillel Galitzer is 41, he's been the Chief Operating Officer of Entera Bio Ltd since 2014. There are 16 older and 2 younger executives at Entera Bio Ltd. The oldest executive at Entera Bio Ltd is Gerald Lieberman, 73, who is the Independent Chairman of the Board.

What's Hillel Galitzer's mailing address?

Hillel's mailing address filed with the SEC is KIRYAT HADASH,MINRAV BUILDING,5TH FLOOR, , JERUSALEM, L3, 9112002.

Insiders trading at Entera Bio Ltd

Over the last 3 years, insiders at Entera Bio Ltd have traded over $0 worth of Entera Bio Ltd stock and bought 467,822 units worth $484,536 . The most active insiders traders include Gerald M Lieberman, Miranda Jayne Toledano, and Sean Ellis. On average, Entera Bio Ltd executives and independent directors trade stock every 32 days with the average trade being worth of $36,205. The most recent stock trade was executed by Haya Taitel on 12 January 2024, trading 9,500 units of ENTX stock currently worth $9,405.

What does Entera Bio Ltd do?

entera bio ltd. is a biotechnology company located in israel.

Entera Bio Ltd executives and stock owners

Entera Bio Ltd executives and other stock owners filed with the SEC include:

• Phillip Schwartz,
  President of Research and Development
• Gerald Lieberman,
  Independent Chairman of the Board
• Arthur Santora,
  Chief Medical Officer
• Dr. Phillip Schwartz Ph.D.,
  Exec. VP, Pres of R&D and Director
• Roger Garceau,
  Chief Executive Officer, Director
• Hillel Galitzer,
  Chief Operating Officer
• Dr. Hillel Galitzer,
  Chief Operating Officer
• Dr. Arthur C. Santora II, M.D., Ph.D.,
  Chief Medical Officer
• Kiryat Hadassah,
  IR Contact Officer
• Miranda Toledano,
  Independent Director
• Gerald Ostrov,
  Independent Director
• Faith Charles,
  Independent Director
• Yonatan Malca,
  Director
• Sean Ellis,
  Director
• Zeev Bronfeld,
  Director
• Jonathan Lieber,
  Chief Financial Officer - U.S.-based
• Dana Yaacov-Garbeli,
  Chief Financial Officer
• Dr. Roger J. Garceau,
  Chief Devel. Advisor & Director
• Ramesh Ratan,
  U.S. Chief Financial Officer
• Dana Yaacov-Garbeli CPA,
  Chief Financial Officer
• Dr. Spiros Jamas,
  CEO & Director
• Haya Taitel,
  Director
• Ramesh Ratan,
  U.S.based CFO
• Spiros Jamas,
  Chief Executive Officer
• Ron Mayron,
  Director